Boston Scientific Corp at JPMorgan Healthcare Conference Transcript
Hello everyone. Welcome. I'm Robbie Marcus, the med tech analyst at JP Morgan. Really happy to host Boston Scientific. We have, Mike Mahoney, CEO, John Monson, CFO, and Doctor Stein, Chief Medical Officer.
We're going to do a fireside chat here. Lots to talk about.
Maybe we could just start. We're coming into, we'll get, fourth quarter earnings in a couple weeks here coming into 2026. You have a lot of new products launching this year. You have a lot of great products growing very healthy, great margin expansion. How are you thinking about the business? How do you feel coming into 2026?
Good morning, Robbie. Good morning, everyone. I feel great about where we are as a company.
We had our investor day a few months ago and.
Really, not there's some good news since then, but not much has changed. We committed to 10% growth, 10% plus growth over the three year period, 150 bits of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
